If You Cannot Grow it, Clone it! Hepatitis C Update

References

• CDC: Years of potential life lost before ages 65 and 85—United States, 1989–1990. MMWR 41: 313–315, 1992.
   PubMedGoogle Scholar
• Marengo-Rowe AJ: Hepatitis C. Baylor University Medical Center Proceedings 3 (4): 3–12, 1990.
   Google Scholar
• Choo QL, Kuo G, Weiner AJ, et al: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359–362, 1989.
   PubMed Web of Science ®Google Scholar
• Kuo G, Choo QL, Alter HJ, et al: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244: 362–364, 1989.
   PubMed Web of Science ®Google Scholar
• Van der Poel CL, Reesink HW, Leslie PN, et al: Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 2: 297–298, 1989.
   PubMed Web of Science ®Google Scholar
• Esteban JI, Esteban R, Viladomiu L, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2: 294–297, 1989.
   PubMed Web of Science ®Google Scholar
• Alter HJ, Purcell RH, Shih JW, et al: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321: 1494–1500, 1989.
   PubMed Web of Science ®Google Scholar
• Miyamura T, Saito I, Katayama T, et al: Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 87: 983–987, 1990.
   PubMed Web of Science ®Google Scholar
• Choo QL, Weiner AJ, Overby LR, et al: Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46: 423–441, 1990.
   PubMed Web of Science ®Google Scholar
• Proceedings First International Symposium: Hepatitis C Virus, Rome, Italy, Sept 14–15, 1989, pp 9–25.
   Google Scholar
• Van der Poel CL, Reesink HW, Schaasberg W, et al: Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 335: 558–560, 1990.
   PubMed Web of Science ®Google Scholar
• Garson JA, Tedder RS, Briggs M, et al: Detection of hepatitis C viral sequences in blood donations by “nested” polymerase chain reaction and prediction of infectivity. Lancet 335: 1419–1422, 1990.
   PubMed Web of Science ®Google Scholar
• Van der Poel CL, Reesink HW, Lelie PN, et al: Anti-HCV and transaminase testing of blood donors. Lancet 336: 187–188, 1990.
   Web of Science ®Google Scholar
• Ebeling F, Naukkarinen R, Leikola J: Recombinant immunoblot assay for hepatitis C antibody as predictor of infectivity. Lancet 335: 982–983, 1990.
   PubMed Web of Science ®Google Scholar
• Houghton M, Weiner A, Han J, et al: Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology 14: 381–388, 1991.
   PubMed Web of Science ®Google Scholar
• Chan SW, Simmonds P, McOmish F, et al: Serological responses to infection with three different types of hepatitis C virus. Lancet 338: 1391, 1991.
   Web of Science ®Google Scholar
• Choo QL, Richman KH, Han JH, et al: Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88: 2451–2455, 1991.
   PubMed Web of Science ®Google Scholar
• Kato N, Hijikata M, Ootsuyama Y, et al: Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 87: 9524–9528, 1990.
   PubMed Web of Science ®Google Scholar
• Takamizawa A, Mori C, Fuke I, et al: Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65: 1105–1113, 1991.
   PubMed Web of Science ®Google Scholar
• Kato N, Ohkoshi S, Shimotohno K: Japanese isolates of the non-A, non-B hepatitis viral genome show sequence variations from the original isolate in the USA. Proceedings of Japanese Academy of Medicine 65B: 219–223, 1989.
   Google Scholar
• Maeno M, Kaminaka K, Sugimoto H, et al: A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res 18: 2685–2689, 1990.
   PubMed Web of Science ®Google Scholar
• Weiner AJ, Brauer MJ, Rosenblatt J, et al: Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180: 842–848, 1991.
   PubMed Web of Science ®Google Scholar
• Enmoto N, Takada A, Nakao T, et al: There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 170: 1021–1025, 1990.
   Web of Science ®Google Scholar
• Ortho HCV 2.0 ELISA Test System, package insert, New Brunswick, New Jersey, March 1992.
   Google Scholar
• McHutchinson JG, Person JL, Govindarajan S, et al: Improved detection of hepatitis C virus antibodies in high risk populations. Hepatology 15: 19–25, 1992.
   Web of Science ®Google Scholar
• Van der Poel CL, Bresters D, Reesink HW, et al: Early antihepatitis C virus response with second-generation c200/-c22 ELISA. Vox Sang 62: 208–212, 1992.
   PubMed Web of Science ®Google Scholar
• Van der Poel CL, Cuypers HTM, Reesink HW, et al: Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 337: 317–319, 1991.
   PubMed Web of Science ®Google Scholar
• Farci P, Wong D, Alter HJ, et al: Detection of HCV sequences by PCR in hepatitis C virus infection: relationship to antibody response and clinical outcome. Hepatology 12: 904, 1990.
   Web of Science ®Google Scholar
• Farci P, Alter HJ, Wong D, et al: A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 325: 98–104, 1991.
   PubMed Web of Science ®Google Scholar
• Busch MP, Wilber JC: Hepatitis C replication. (letter) N Engl J Med 326: 64–65, 1992.
   Google Scholar
• Goeser T, Muller H, Padron G, et al: Hepatitis C virus replication. (letter) N Engl J Med 326: 65, 1992.
   Google Scholar
• Alter MJ, Hadler SC, Judson FN, et al: Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 264: 2231–2235, 1990.
   PubMed Web of Science ®Google Scholar
• Alter MJ: Hepatitis C: a sleeping giant? Am J Med 91 (3B): 112S–115S, 1991.
   Google Scholar
• Colombo M, Rumi MG, Donato MF, et al: Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Dig Dis Sci 36: 1130–1133, 1991.
   Web of Science ®Google Scholar
• Kaklamani E, Trichopoulos D, Tzonou A, et al: Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265: 1974–1976, 1991.
   PubMed Web of Science ®Google Scholar
• Alter MJ, Coleman PJ, Alexander WJ, et al: Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 262: 1201–1205, 1989.
   PubMed Web of Science ®Google Scholar
• Everhart JE, Di Bisceglie AM, Murray LM, et al: Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 112: 544–545, 1990.
   PubMed Web of Science ®Google Scholar
• Tedder RS, Gilson RJC, Briggs M, et al: Hepatitis C virus: evidence for sexual transmission. Br Med J 302: 1299–1302, 1991.
   PubMedGoogle Scholar
• Riestra S, Carcaba V: Hepatitis C virus: evidence for sexual transmission. (letter) Br Med J 303: 406–407, 1991.
   Google Scholar
• Alter MJ, Coleman PJ, Alexander WJ, et al: Potential importance of the sexual transmission of non-A, non-B hepatitis. (abstract) Hepatology 13: 805–808, 1991.
   Web of Science ®Google Scholar
• Vanderschueren S, Van Renterghem L, Plum J, et al: Hepatitis C among risk groups for HIV and hepatitis B. International Journal of STD and AIDS 2: 185–187, 1991.
   Google Scholar
• Brettler DB, Mannucci PM, Gringeri A, et al: The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophiliac males: an international, multicenter study. Blood 80: 540–543, 1992.
   PubMed Web of Science ®Google Scholar
• Reesink HW, Wong VCW, Ip HMH, et al: Mother-to-infant transmission of hepatitis C virus. Lancet 335: 1216–1217, 1990.
   PubMed Web of Science ®Google Scholar
• Reesink HW, Wong VCW, Ip HMH: Mother-to-child transmission of hepatitis C virus. J Infect Dis 164: 427–428, 1991.
   Web of Science ®Google Scholar
• Ideo G, Bellati G, Pedraglio E, et al: Intrafamilial transmission of hepatitis C virus. (letter) Lancet 335: 353, 1990.
   PubMed Web of Science ®Google Scholar
• Wang JT, Wang TH, Lin JT, et al: Hepatitis C virus RNA in saliva of patients with post-transfusion hepatitis C infection. (letter) Lancet 337: 48, 1991.
   PubMed Web of Science ®Google Scholar
• Dusheiko GM, Smith M, Scheuer PJ: Hepatitis C virus transmitted by human bite. (letter) Lancet 336: 503–504, 1990.
   PubMed Web of Science ®Google Scholar
• Abe K, Kurata T, Shikata T, et al: Experimental transmission of non-A, non-B hepatitis by saliva. J Infect Dis 155: 1078–1079, 1987.
   Web of Science ®Google Scholar
• Klein RS, Freeman K, Taylor PE, et al: Occupational risk for hepatitis C virus infection among New York dentists. Lancet 338: 1539–1542, 1991.
   PubMed Web of Science ®Google Scholar
• Feinstone SM, Kapikian AZ, Purcell RH, et al: Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292: 767–770, 1975.
   PubMed Web of Science ®Google Scholar
• Tabor E, Hoofnagle JH, Smallwood LA, et al: Studies of donors who transmit posttransfusion hepatitis. Transfusion 19: 725–731, 1979.
   PubMed Web of Science ®Google Scholar
• Hernandez JM, Piqueras J, Carrera A, et al: Posttransfusion hepatitis in Spain: a prospective study. Vox Sang 44: 231–237, 1983.
   PubMed Web of Science ®Google Scholar
• Stevens CE, Aach RD, Hollinger FB, et al: Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients: an analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 101: 733–738, 1984.
   PubMed Web of Science ®Google Scholar
• Williams AE, Dodd RY: The serology of hepatitis C virus in relation to posttransfusion hepatitis. Ann Clin Lab Sci 20: 192–199, 1990.
   Web of Science ®Google Scholar
• Inaba S, Fukuda M, Okochi K, et al: HCV transmission after receiving anti-c100-negative blood units. (letter) Lancet 337: 1354, 1991.
   Web of Science ®Google Scholar
• Watanabe J, Matumoto C, Nishioka K, et al: Anti-GOR to screen HCV-RNA-positive blood donors. (letter) Lancet 338: 391, 1991.
   Google Scholar
• Esteban JI, Gonzales A, Hernandez JM, et al: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323: 1107–1112, 1990.
   PubMed Web of Science ®Google Scholar
• Hollinger FB, Mosley JW, Szmuness W, et al: Non-A, non-B hepatitis following blood transfusion: risk factors associated with donor characteristics. In Szmuness W, Alter HJ, Maynard JE, eds: Viral Hepatitis: 1981 International Symposium. Philadelphia. PA, Franklin Institute Press, 1982, pp 361–376.
   Google Scholar
• Mosley JW, Aach RD, Hollinger FB, et al: Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 263: 77–78, 1990.
   PubMed Web of Science ®Google Scholar
• Contreras M, Barbara JA, Anderson CC, et al: Low incidence of non-A, non-B posttransfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet 337: 753–757, 1991.
   PubMed Web of Science ®Google Scholar
• Donahue JG, Alvaro Muzoz DVM, Ness PM, et al: The declining risk of posttransfusion hepatitis C virus infection. N Engl J Med 327: 369–373, 1992.
   PubMed Web of Science ®Google Scholar
• Mosley JR, Redeker AG, Feinstone SM, et al: Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 296: 75–78, 1977.
   PubMed Web of Science ®Google Scholar
• Yoshizawa H, Itoh Y, Iwakiri S, et al: Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies of chimpanzees. Gastroenterology 81: 107–113, 1981.
   PubMed Web of Science ®Google Scholar
• Bradley DW, Maynard JE, Popper H, et al: Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 148: 254–265, 1983.
   PubMed Web of Science ®Google Scholar
• Koziol DE, Holland PV, Ailing DW, et al: Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 104: 488–495, 1986.
   PubMed Web of Science ®Google Scholar
• Hyo-Suk L, Rajagopalan MS, Chien D, et al: Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors. Transfusion 27: 103–106, 1987.
   Web of Science ®Google Scholar
• Alter HJ, Purcell RH, Holland PV, et al: Donor transaminase and recipient hepatitis: impact on blood transfusion services. JAMA 246: 630–634, 1981.
   PubMed Web of Science ®Google Scholar
• Larsen J, Hetland G, Skaug K: Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion 30: 431–432, 1990.
   PubMed Web of Science ®Google Scholar
• Hoofnagle JH: Posttransfusion hepatitis B. Transfusion 30: 384–386, 1990.
   PubMed Web of Science ®Google Scholar
• Dodd RY, Popovsky MA, and members of the Scientific Section Coordinating Committee: Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Transfusion 31: 443–449, 1991.
   Web of Science ®Google Scholar
• Baur P, Daniel V, Pomer S, et al: Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation. Annals of Hematology 62 (2–3): 68–73, 1991.
   Web of Science ®Google Scholar
• Fernandez JA, Roth D, Burke G, et al: Detection of antibody to hepatitis C virus (HCV) in renal transplant recipients. Transplant Proc 23: 444–445, 1991.
   Google Scholar
• Lunel F, Cadranel JF, Perrin M, et al: Anti-hepatitis C virus (HCV) antibodies in heart transplant recipients with posttransplantation chronic viral B and non-A, non-B hepatitis. Dig Dis Sci 36: 124–125, 1991.
   Web of Science ®Google Scholar
• Pereira BJ, Milford EL, Kirkman RL, et al: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 325: 454–460, 1991.
   PubMed Web of Science ®Google Scholar
• Cariani E, Zonaro A, Primi D, et al: Detection of HCV RNA and antibodies to HCV after needlestick injury. (letter) Lancet 337: 850, 1991.
   PubMed Web of Science ®Google Scholar
• Kiyosawa K, Sodeyama T, Tanaka E, et al: Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 115: 367–369, 1991.
   PubMed Web of Science ®Google Scholar
• Masuko K, Mitsui T, Iwano K, et al: Factors influencing postexposure immunoprophylaxis of hepatitis B virus infection with hepatitis B immune globulin: high DNA polymerase activity in the inocula of unsuccessful cases. Gastroenterology 88: 151–155, 1985.
   PubMed Web of Science ®Google Scholar
• Hibbs JR, Frickhofen N, Rosenfeld SJ, et al: Aplastic anemia and viral hepatitis. Non-A, non-B, non-C? JAMA 267: 2051–2054, 1992.
   Google Scholar
• Knodell RG, Conrad ME, Ginsberg AL, et al: Efficacy of prophylactic gamma-globulin in preventing non-A. non-B post-transfusion hepatitis. Lancet 1: 557–561, 1976.
   PubMed Web of Science ®Google Scholar
• Seeff LB, Zimmerman HG, Wright EC, et al: A randomized double blind controlled trial of the efficacy of immune serum globulin for the prevention of posttransfusion hepatitis. Gastroenterology 72: 111–121, 1977.
   PubMed Web of Science ®Google Scholar
• Sanchez-Quijano A, Pineda JA, Lissen E, et al: Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1: 1245–1249, 1988.
   Web of Science ®Google Scholar
• Al-Khaja N, Roberts DG, Belboul A, et al: Gamma globulin prophylaxis to reduce posttransfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg 25: 7–12, 1991.
   Web of Science ®Google Scholar
• Schumacher K, Maerker-Alzer G, Kleinau T, et al: Passive immunoprophyaxe der posttransfusion hepatitis durch Immunoglobulin-Praparationen. Dtsch Med Wochenschr 170: 1459–1464, 1982.
   Google Scholar
• Stokes P, Lopez WC, Balart LA: Effects of short-term corticosteroid therapy in patients with chronic non-A, non-B hepatitis. (abstract) Gastroenterology 92: 1783, 1987.
   Web of Science ®Google Scholar
• Pappas SC, Hoffnagle JH, Young N, et al: Treatment of chronic non-A, non-B hepatitis with Acyclovir: a pilot study. J Med Virol 15: 1–9, 1985.
   PubMed Web of Science ®Google Scholar
• Davis GL, Balart LA, Schiff ER, et al: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial. N Engl J Med 321: 1501–1506, 1989.
   PubMed Web of Science ®Google Scholar
• Di Bisceglie AM, Martin P, Kassianides C, et al: Recombinant interferon alfa therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 321: 1506–1510, 1989.
   PubMed Web of Science ®Google Scholar
• Saez-Royuela F, Porres J, Moreno A, et al: High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial. Hepatology 13: 327–331, 1991.
   PubMed Web of Science ®Google Scholar
• Ohnishi MD, Nomura F, Nakamo M: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol 86: 1041–1049, 1991.
   PubMed Web of Science ®Google Scholar
• Kanai K, Iwata K, Nakao K, et al: Suppression of hepatitis C virus RNA by interferon-alpha. Lancet 336: 245, 1990.
   PubMed Web of Science ®Google Scholar
• Pozzato G, Moretti M, Franzin F, et al: Severity of liver disease with different hepatitis C viral clones. Lancet 338: 509, 1991.
   PubMed Web of Science ®Google Scholar
• Kanai K, Kako M, Okamoto H: HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339: 1543, 1992.
   PubMed Web of Science ®Google Scholar
• Vento S, Garofano T, Di Perri G, et al: Zidovudine therapy associated with remission of chronic active hepatitis C in HIV-1 carriers. (letter) Aids 5: 776, 1991.
   Web of Science ®Google Scholar
• Reichard O, Andersson J, Schvarcz R, et al: Ribavirin treatment for chronic hepatitis C. Lancet 337: 1058–1061, 1991.
   PubMed Web of Science ®Google Scholar
• Low TLK, Thurman GB, McAdoo M, et al: Isolation characterization and biological activities of thymosin alpha-1 and polypeptide beta-1 from calf thymus. J Biol Chem 254: 981–986, 1979.
   PubMed Web of Science ®Google Scholar
• Mutchnick MG, Appelman HD, Chung HT, et al: Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Hepatology 14: 409–415, 1991.
   PubMed Web of Science ®Google Scholar
• Kolho E, Naukkarinen R, Krusius T: Specificity and sensitivity of two second-generation ELISA tests in detecting hepatitis C antibodies in blood donors known to be reactive with a supplemental assay. Vox Sang 63: 158–160, 1992.
   Web of Science ®Google Scholar
• Larsen J Shaug K Maeland A: Second-generation anti-HCV tests predict infectivity. Vox Sang 63: 39–42, 1992.
   Web of Science ®Google Scholar